Taiwan’s Formosa Pharmaceuticals Partners with Medvisis to Launch Innovative Ophthalmic Treatment in Switzerland and Liechtenstein

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Medvisis Switze...

November 29, 2024 | Friday | News
Taiwan’s Bora Pharmaceuticals Expands Rare Disease Portfolio with Acquisition of U.S.-Based Pyros Pharmaceuticals

Bora Pharmaceuticals Co., Ltd. ("Bora" or "the Company", TWSE: 6472),  announced that its Board of Directors has approved the acquisition of US-based ...

October 28, 2024 | Monday | News
Emergent BioSolutions Completes $30 Million Sale of Baltimore-Camden Facility to Bora Pharmaceuticals

Emergent BioSolutions Inc.  announced it has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of B...

August 21, 2024 | Wednesday | News
Parse Biosciences Partners with Prisma Biotech to Expand Single-Cell Sequencing Reach in Asia-Pacific

-Parse Biosciences, a leading provider of cost-effective and scalable solutions for single-cell sequencing, today announced an agreement with the Taiwane...

August 08, 2024 | Thursday | News
Taiwan's Senhwa Biosciences Submits IND to US FDA for Phase I/II Study of Silmitasertib in Pediatric Cancer Treatment

  Senhwa Biosciences, Inc. (TPEx: 6492), announced IND Submission to US FDA for the Phase I/II study of Silmitasertib (CX-4945) in combination with c...

July 12, 2024 | Friday | News
Bora Pharmaceuticals Expands US Presence with Acquisition of Emergent BioSolutions’ Sterile Manufacturing Facility in Baltimore

Bora Pharmaceuticals Co., Ltd.  announced that it has successfully entered into an agreement for Emergent BioSolutions’  sterile man...

June 21, 2024 | Friday | News
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia

Incyte and China Medical System Holdings Limited  are pleased to announce that on March 31, 2024, Incyte and CMS, through a wholly-owned dermatology m...

April 02, 2024 | Tuesday | News
Bora Pharmaceuticals Completes Acquisition of Upsher-Smith Laboratories, Fortifying Presence in U.S. Generics Market

Bora Pharmaceuticals Co., Ltd.  announced that it has completed the acquisition of Upsher-Smith  Laboratories, LLC. (“Upsher-Smith”),...

April 02, 2024 | Tuesday | News
Registration Now Open for BIO Asia–Taiwan 2024: A Keystone Event for Asia's Biotech Industry

  The highly anticipated BIO Asia–Taiwan 2024 has officially opened its registration for attendees. Scheduled to take place from July 24 to 28 ...

February 26, 2024 | Monday | News
Travere Licenses Sparsentan to Renalys Pharma for Japan, South Korea, Taiwan, and Southeast Asia

Travere Therapeutics, Inc. announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endot...

January 26, 2024 | Friday | News
Bora Pharmaceuticals Acquires Upsher-Smith for $210M to Drive Global Growth

Upsher-Smith, founded in 1919 and owned by Sawai since 2017, has a diversified portfolio of 48 generic products with manufacturing facilities in Plymouth a...

January 17, 2024 | Wednesday | News
Senhwa Biosciences Gains Taiwan FDA Approval for Silmitasertib Phase II Study in Viral-Associated Community-Acquired Pneumonia (CAP)

The trial is a phase II multi-center, randomized-controlled interventional prospective study, and the purpose of this trial is to investigate whether early...

December 27, 2023 | Wednesday | News
Everest Medicines' Nefecon® NDA Accepted in Taiwan for Adult Primary IgA Nephropathy

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization ...

December 27, 2023 | Wednesday | News
Polaris Group Acquires Genovior Biotech in Dual-Engine Growth Move in Taiwan

Additionally, Dr. Steve Hsu, Chairman of Genovior Biotech Corporation, has been appointed as the CEO of Polaris Group. This significant decision not only a...

December 26, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close